Recurrence Score Indicates When to Use Endocrine Therapy : v

Scores on a breast recurrence assay may signal which patients can get neoadjuvant endocrine therapy vs chemotherapy. The study was published as a preprint and has not yet been peer reviewed.

Related Keywords

United States , , Research Squareas , Emory University Winship Cancer Institute , Massey Cancer Center At Virginia Commonwealth University , Recurrence Score , Emory University , Winship Cancer Institute , Massey Cancer Center , Virginia Commonwealth , Breast Cancer , Alignant Breast Neoplasm , Endocrine Therapy , Breast , Neoadjuvant , Chemotherapy , Cancer , Alignant Neoplasia , Arcinoma , Peer Review , Receptors , Patient Safety , Adverse Effects , Side Effects , Virginia ,